Basic Information
LncRNA/CircRNA Name | CASC11 |
Synonyms | NA |
Region | GRCh38_8:127686343-127733967 |
Ensemble | ENSG00000249375 |
Refseq | NR_117101 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | small cell lung cancer |
ICD-0-3 | C56.9 |
Methods | qPCR, Western blot |
Sample | Human SCLC cell lines SHP-77 (ATCC? CRL-2195), DMS 79 (ATCC? CRL-2049), H345 (ATCC? HTB-180), DMS 53 (ATCC? CRL-2062), H446(ATCC? HTB-171) and H1341 (ATCC? CRL-5864) |
Expression Pattern | up-regulated |
Function Description | Plasma lncRNA CASC11 and TGF-?1 mRNA were upregulated in SCLC patients |
Pubmed ID | 30965130 |
Year | 2019 |
Title | LncRNA CASC11 promotes TGF-?1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer. |
External Links
Links for CASC11 | GenBank HGNC NONCODE |
Links for small cell lung cancer | OMIM COSMIC |